Video Back Videos home Signature collection Essentials collection Artificial Intelligence ...

NICE has produced a resource impact template and a resource impact summary report that incorporates the following technology appraisal guidance for managing overweight and obesity: Overweight and ...

Amid the rising buzz around Ozempic and similar weight-loss drugs, a group of 58 researchers is challenging the way obesity is defined and diagnosed, arguing that current methods fail to capture ...

A group of experts from around the world are proposing an alternative way of defining clinical obesity, eschewing the commonly referenced body max index (BMI) and instead approaching the condition ...

New Insights Into the Biology and Risk Factors of Childhood Obesity Jan. 15, 2025 — A cutting-edge molecular approach provides a detailed picture of the biological pathways associated with ...

New guidance from a team of health experts around the world proposes expanding the definition of obesity beyond the popular body mass index (BMI) measure. The new guidance comes from the ...

The new definitions aim to resolve any conflict in medical circles over whether obesity is a disease or just a risk factor. Global health leaders have proposed a “dramatic overhaul” of the way ...

Kushner helped craft the new definition of obesity as part of the Lancet Diabetes and Endocrinology Special Commission. Instead of relying on a single number – BMI – doctors are calling for a ...

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for ... [+] health insurers, employers and government health programs who cover it in 2025.

Since Zepbound was approved by the FDA to treat obesity in late 2023, its maker Eli Lilly has been steadily closing in on fierce rival Novo Nordisk’s early lead in the obesity market.